Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02299921

Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study plans to learn more about people who are sick in the hospital with a lung infection, or respiratory failure. Respiratory failure, or severe lung failure, is a life-threatening disease. When it happens, the lungs have trouble carrying out their normal function of getting oxygen into the blood, and removing carbon dioxide from the body. Investigators are conducting this study to see what drinking too much alcohol, using tobacco products, or using drugs (both legal and illegal) may do to lung infections and respiratory failure. Subjects are asked to be in this research study because they are thought to have a lung infection and may also have respiratory failure. Alcohol, tobacco, and drug use have been linked to lung infections, respiratory failure, and even death, but the reasons for this aren't known. People who use unhealthy amounts of alcohol, tobacco, and or drugs may be more at risk for lung infections, and for severe complications due to lung infection. Subject participation is important whether or not you use alcohol and or drugs.

Conditions

Interventions

TypeNameDescription
OTHERCharacterize alcohol and drug useCharacterize alcohol and drug use in patients newly admitted to the medical ICU service, who are expected to stay in the ICU for greater than 48 hours. The investigators will collect blood, exhaled breath condensate, urine and hair samples over the first 10 days of hospitalization. A select subset of subjects will have bronchoalveolar lavage (BAL) obtained.

Timeline

Start date
2014-11-01
Primary completion
2029-04-30
Completion
2029-04-30
First posted
2014-11-24
Last updated
2024-10-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02299921. Inclusion in this directory is not an endorsement.